LCM
JAZZ icon

Logan Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Logan Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,568
Closed -$485K – 561
2026
Q1 		$485K Buy
+2,568
New +$449K 0.02% 246

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Logan Capital Management's JAZZ Position: Q2 2026 in Review

Logan Capital Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 2,580 shares worth $622K. The stake represents 0.02% of the portfolio and ranks #233 among its holdings. This is a return to the name: Logan Capital Management previously reported a position in JAZZ as recently as Q4 2025.

Logan Capital Management first reported a position in JAZZ in Q2 2015 and has held it in 29 quarters since. The position peaked at $671K in Q1 2022. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Logan Capital Management held 2,580 shares of Jazz Pharmaceuticals worth $622K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Logan Capital Management position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.02% of Logan Capital Management's portfolio in Q2 2026, its #233 holding.
  • Logan Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2015 and has held it in 29 quarters since.
  • Logan Capital Management's Jazz Pharmaceuticals position peaked at $671K in Q1 2022.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Logan Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.